Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life Study.

CONCLUSION: Sofosbuvir/ledipasvir regimen seems to be safe and highly effective in treatment of chronic HCV in patients with β-thalassemia major.
PMID: 33530921 [PubMed - as supplied by publisher]

Source: Endocrine, Metabolic and Immune Disorders Drug Targets - February 4, 2021 Category: Drugs & Pharmacology Tags: Endocr Metab Immune Disord Drug Targets Source Type: research